Results 281 to 290 of about 16,272 (302)

Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

Journal of Mass Spectrometry, 2003
Frank T Peters, Roland F Staack, Thomas Kraemer   +2 more
exaly  

Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs

Biochemical Pharmacology, 2000
Karl-Artur Kovář, Matthias Schwab, Ulrich M Zanger   +2 more
exaly  

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)

Toxicology Letters, 2000
Hans H Maurer, Thomas Kraemer, Frank T Peters   +2 more
exaly  

Laser Lights and Designer Drugs: New Techniques for Descending Levels of Mechanisms “in a Single Bound”?

Topics in Cognitive Science, 2020
John Bickle
exaly  

Stability study of the designer drugs “MDA, MDMA and MDEA” in water, serum, whole blood, and urine under various storage temperatures

Forensic Science International, 2001
Jan F Van Bocxlaer, André P De Leenheer
exaly  

Simultaneous determination of ten amphetamine designer drugs in human whole blood by capillary electrophoresis with diode array detection

Biomedical Chromatography, 2005
Maria Nieddu, Gianpiero Boatto, Antonio Carta   +2 more
exaly  

Cross-reactivities of 41 new amphetamine designer drugs to EMIT® immunoassays

Forensic Toxicology, 2012
Maria Nieddu, Lucia Burrai, Maria Antonietta Pirisi   +2 more
exaly  

Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection

Journal of Chromatography A, 2007
Gianpiero Boatto, Maria Nieddu
exaly  

“Not for Human Consumption”: A Review of Emerging Designer Drugs

Pharmacotherapy, 2014
exaly  

Drug Design

1990
openaire   +1 more source